Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity
Science · 09.04.2026 · 392 (6794)
DOI: 10.1126/science.ady5196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 09.04.2026. Verfasst von Jooho Chung und 39 weiteren Autor:innen. Beteiligte Einrichtung: Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA. Hauptthemen laut MEDLINE: Phagocytosis, Leukemia, Myeloid, Acute, Macrophages, Leukosialin. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: National Institutes of Health, Damon Runyon Cancer Research Foundation, Edward P. Evans Foundation.
Abstract (Originalsprache)
Macrophages exert antitumorigenic activity through phagocytosis, but phagocytosis-enhancing therapeutics have not improved acute myeloid leukemia (AML) outcomes. To identify phagocytosis regulators, we performed CRISPR knockout screens in human AML cells cocultured with human macrophages. We found that the “don’t eat me” signal CD47 inhibited mouse but not human macrophage phagocytosis. However, O-linked glycosylation and sialylation were strong negative regulators of phagocytosis. In AML, the cell surface mucin-like glycoprotein CD43 was the major effector of these pathways. Inhibition of phagocytosis by CD43 was dependent on the length of its ectodomain and independent of the macrophage sialic acid receptors SIGLEC-1, SIGLEC-7, and SIGLEC-9. The inhibitory effects of CD43 extended beyond human macrophages to natural killer and T cells. Thus, CD43 forms a glyco-immune barrier that restrains both innate and adaptive antileukemic immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
- Krantz Family Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.
- Division of Hematology and Oncology, Massachusetts General Brigham Cancer Center, Boston, MA, USA.
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
- Department of Clinical and Laboratory Genetics, Medical University of Lodz, Lodz, Poland.
- Department of Chemotherapy, Copernicus Memorial Hospital, Lodz, Poland.
ORCID-Profile: Jooho Chung, Mounica Vallurupalli, Sarah Noel, Gail Schor, Sofia Mrowka, Ilario Scapozza, Zelalem Demere, Jonathan J Perera, Ewa Wrona, Collins K Cheruiyot, Yunkang Lin, David W Wu, Cun Lan Chuong, Filippo Birocchi, Ashwin V Kammula, Omar I Avila, John G Doench, Dean Procter, Andrew M Brunner, Daniel J DeAngelo, Jacqueline S Garcia, Russell W Jenkins, Marcela V Maus, Timothy A Graubert, Kathleen B Yates, Todd R Golub, Robert T Manguso
Förderung
- National Institutes of Health
- Damon Runyon Cancer Research Foundation
- Edward P. Evans Foundation
- NHLBI Division of Intramural Research
- Calico Life Sciences LLC
- Polish National Agency for Academic Exchange – the Walczak Programme
Zitieren
APA
Chung, J., Vallurupalli, M., Noel, S., Schor, G., Mrowka, S., Scapozza, I., Demere, Z., Kammula, S. V., Hu, M., Kim, S. Y., Liu, Y., Nobrega, C., Perera, J. J., Wrona, E., Cheruiyot, C. K., Lin, Y., Wu, D. W., Saberi, M., Cruickshank, A., …, & Manguso, R. T. (2026). Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity. Science, 392(6794). https://doi.org/10.1126/science.ady5196
Vancouver
Chung J, Vallurupalli M, Noel S, Schor G, Mrowka S, Scapozza I, et al. Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity. Science. 2026;392(6794). doi:10.1126/science.ady5196
BibTeX
@article{Chung2026,
author = {Chung, Jooho and Vallurupalli, Mounica and Noel, Sarah and Schor, Gail and Mrowka, Sofia and Scapozza, Ilario and Demere, Zelalem and Kammula, Sachin V and Hu, Margaret and Kim, Sarah Y and Liu, YuhJong and Nobrega, Celeste and Perera, Jonathan J and Wrona, Ewa and Cheruiyot, Collins K and Lin, Yunkang and Wu, David W and Saberi, Maria and Cruickshank, Aidan and Woods, Elliot C and Chuong, Cun Lan and Birocchi, Filippo and Kammula, Ashwin V and Avila, Omar I and Knudsen, Nelson and Kocak, Mustafa and Doench, John G and Procter, Dean and Thornton, Lindsey and Brunner, Andrew M and Winer, Eric and DeAngelo, Daniel J and Garcia, Jacqueline S and Stone, Richard M and Jenkins, Russell W and Maus, Marcela V and Graubert, Timothy A and Yates, Kathleen B and Golub, Todd R and Manguso, Robert T},
title = {Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity},
journal = {Science},
year = {2026},
volume = {392},
number = {6794},
doi = {10.1126/science.ady5196}
}
EUVIMED